10% Owner
10% Owner at InMed Pharmaceuticals Inc., filing insider transactions between 2025-10-15 and 2026-05-19. Also reports transactions at 2 other companies.
| SEC ↗ |
| 2026-05-19 | RLYB | Purchase | 200 | $13.80 | $3K | SEC ↗ |
| 2026-05-19 | RLYB | Purchase | 10.0K | $13.98 | $140K | SEC ↗ |
| 2026-05-18 | RLYB | Purchase | 6,009 | $13.98 | $84K | SEC ↗ |
| 2026-05-15 | RLYB | Purchase | 200 | $13.95 | $3K | SEC ↗ |
| 2026-05-15 | RLYB | Purchase | 100 | $13.80 | $1K | SEC ↗ |
| 2026-05-13 | RLYB | Purchase | 4,081 | $13.80 | $56K | SEC ↗ |
| 2026-05-13 | RLYB | Purchase | 75.2K | $14.00 | $1.1M | SEC ↗ |
| 2026-05-12 | RLYB | Purchase | 800 | $13.83 | $11K | SEC ↗ |
| 2026-05-11 | RLYB | Purchase | 19.9K | $14.00 | $279K | SEC ↗ |
| 2026-05-11 | RLYB | Purchase | 25.0K | $14.00 | $350K | SEC ↗ |
| 2026-05-11 | RLYB | Purchase | 5,100 | $14.00 | $71K | SEC ↗ |
| 2026-05-05 | RLYB | Purchase | 35.1K | $14.00 | $491K | SEC ↗ |
| 2026-05-04 | RLYB | Purchase | 3,900 | $13.90 | $54K | SEC ↗ |
| 2026-05-04 | RLYB | Purchase | 116.9K | $13.97 | $1.6M | SEC ↗ |
| 2025-10-15 | KROS | Sale | 4.39M | $17.75 | $77.9M | SEC ↗ |
| 2025-10-15 | KROS | Sale | 254.7K | $17.75 | $4.5M | SEC ↗ |
| 2025-10-15 | KROS | Sale | 743.4K | $17.75 | $13.2M | SEC ↗ |